Jacek Sein Anand

Prof. Jacek Sein Anand

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
PNPawel Niedzialkowski
Pawel Niedzialkowski
ZCZ. Cebula
Z. Cebula
Natalia MalinowskaNatalia Malinowska
Natalia Malinowska
WBW. Białobrzeska
W. Białobrzeska
MSMichał Sobaszek
Michał Sobaszek
TOT. Ossowski
T. Ossowski

1 August 2017 in Toxicology Letters
Verified
Journal Article
Closed access
ÒMÒscar Miró
Òscar Miró
MGMiguel Galicia
Miguel Galicia
PDPaul Dargan
Paul Dargan
ADAlison M. Dines
Alison M. Dines
IGIsabelle Giraudon
Isabelle Giraudon
PKPiotr Maciej Kabata
Piotr Maciej Kabata

1 January 2017 in Journal of Chromatography B
Verified
Journal Article
Closed access
MWMarek Wiergowski
Marek Wiergowski
JAJustyna Aszyk
Justyna Aszyk
Michal KaliszanMichal Kaliszan
Michal Kaliszan
KWKamila Wilczewska
Kamila Wilczewska
JAJacek Sein Anand
Jacek Sein Anand
ZJZbigniew Jankowski
Zbigniew Jankowski

1 October 2019 in Toxicology Letters
Verified
Journal Article
Closed access
MGMiguel Galicia
Miguel Galicia
PDPaul I. Dargan
Paul I. Dargan
ADAlison M. Dines
Alison M. Dines
CYChristopher Yates
Christopher Yates
FHFridtjof Heyerdahl
Fridtjof Heyerdahl
SZSergej Zacharov
Sergej Zacharov

1 September 2020 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
AKA. Kulpa
A. Kulpa
Jacek RylJacek Ryl
Jacek Ryl
GSG. Schroeder
G. Schroeder
AKA. Koterwa
A. Koterwa
JAJacek Sein Anand
Jacek Sein Anand
PNPawel Niedzialkowski
Pawel Niedzialkowski

11 March 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WWWojciech Waldman
Wojciech Waldman
PKPiotr M. Kabata
Piotr M. Kabata
ADAlison M. Dines
Alison M. Dines
DWDavid M. Wood
David M. Wood
CYChristopher Yates
Christopher Yates
JAJacek Sein Anand
Jacek Sein Anand
Background: This study was conducted to retrospectively assess the relationships between: rhabdomyolysis (quantified by creatine kinase (CK) activity) and kidney injury (quantified by serum creatinine concentration), sex, age, body temperature on admission, presence of seizures, and agitation or aggression in patients presenting to the Emergency Department with acute recreational drug toxicity. We also investigated the association with the substances ingested. Methods: All presentations to the 16 sentinel Euro-DEN centres in 10 European countries with acute recreational drug toxicity during the first year of the Euro-DEN study (October 2013 to September 2014) were considered. Cases that had abnormal CK activity recorded as part of routine clinical care were divided into 3 cohorts depending on peak CK activity. Cases with normal CK activity were included as a control group (4th cohort). Results: Only 1,015 (18.4%) of the 5,529 Euro-DEN presentations had CK activity concentration recorded. Of this group 353 (34.8%) had also creatinine concentration measured. There were 375 (36.9%) with minor rhabdomyolysis, 69 (6.8%) with moderate rhabdomyolysis, and 24 (2.4%) with severe rhabdomyolysis; 547 (53.9%) were included in the control group. There was a positive correlation between CK activity and creatinine concentration (correlation coefficient r = 0.71, p<0.0001). There was no correlation between CK activity and body temperature at the time of presentation to the ED (correlation coefficient r = 0.07, p = 0.03). There was a positive correlation between CK activity and length of stay in the hospital (r = 0.31, p<0.001). There was no association between CK activity and the presence of seizures (p = 0.33) or agitation/aggression (p = 0.45), patients age (p = 0.4) or sex (p = 0.25). The 5 most common agents amongst patients presenting with rhabdomyolysis were: cocaine (n = 107; 22.9% presentations), amphetamine (76; 16.2%), cannabis (74; 15.8%), GHB/GBL (72; 15.4%) and heroin (67; 14.3%). The distribution of rhabdomyolysis in 5 most common drugs was (drug; patients with rhabdomyolysis, patients without rhabdomyolysis): cocaine (107, 122), cannabis (74, 117), GHB/GBL (72, 81), amphetamine (76, 66), heroin (67, 70). Conclusions: Abnormal values of CK activity occurred in almost half (46.1%) of presentations to the Emergency Department with acute recreational drug toxicity in whom CK activity was measured; however, severe rhabdomyolysis is seen in only a small minority (2.4%). Those with rhabdomyolysis are at significantly higher risk of kidney injury and have a longer length of hospital stay.